The Lancet has announced the formation of its first-ever international commission dedicated exclusively to global skin health, marking a significant shift in how one of the world’s most influential medical journals addresses dermatological conditions. The initiative, developed in collaboration with the International League of Dermatological Societies (ILDS), aims to establish measurable targets for reducing the burden of skin disease worldwide and to strengthen health systems’ capacity to deliver equitable skin care. According to ILDS, which represents over 175,000 dermatologists across more than 100 member societies, the commission represents a pivotal step toward recognizing skin health as an essential component of universal health coverage.
Skin diseases affect an estimated 1.8 billion people globally at any given time, making them among the most prevalent health conditions worldwide. Despite this, dermatological care remains underprioritized in many national health strategies, particularly in low- and middle-income countries where access to trained specialists is limited. The Lancet Commission on Global Skin Health will focus on identifying cost-effective interventions, mapping workforce gaps, and proposing delivery models that can be adapted across diverse economic settings. Its operate will build on growing evidence that skin conditions—ranging from infectious diseases like scabies and fungal infections to chronic disorders such as eczema, psoriasis, and vitiligo—have profound impacts on quality of life, mental health, and economic productivity.
The commission’s establishment follows years of advocacy by dermatology and public health experts calling for greater visibility of skin health in global policy forums. In 2023, the World Health Organization (WHO) included skin diseases in its updated list of neglected tropical diseases (NTDs), acknowledging conditions like leprosy, yaws, and buruli ulcer as priorities for intervention. Though, many common non-communicable skin disorders remain outside formal NTD frameworks, creating gaps in funding and surveillance. The Lancet commission aims to bridge this divide by producing a comprehensive report that integrates clinical, epidemiological, and health systems research to inform policy and practice.
Leadership and Expertise Behind the Initiative
The commission will be co-chaired by Professor Hywel Williams, Director of the Centre of Evidence-Based Dermatology at the University of Nottingham, and Dr. Adebola Adetimehin, a dermatologist and public health specialist based in Nigeria with extensive experience in community-based skin disease programs in sub-Saharan Africa. Williams, a long-time contributor to Cochrane Dermatology and former chair of the International Dermatology Epidemiology Association (IDEAL), brings decades of research leadership in evidence synthesis for skin conditions. Adetimehin has worked with WHO and non-governmental organizations to implement skin health outreach in rural Nigeria, where she has trained community health workers to recognize and manage common dermatological presentations.
Additional commissioners include experts from the London School of Hygiene & Tropical Medicine, the Karolinska Institutet in Sweden, the University of California, San Francisco, and the Indian Council of Medical Research. The group also includes patient advocates and representatives from Indigenous health organizations, reflecting a commitment to centering lived experience in the commission’s recommendations. ILDS confirmed that the commission’s membership balances geographic representation, with members from Africa, Asia, Latin America, Europe, and North America.
Defining the Scope: What Counts as Skin Health?
One of the commission’s first tasks will be to establish a working definition of “global skin health” that goes beyond the absence of disease. Drawing on WHO’s conceptualization of health as a state of complete physical, mental, and social well-being, the commission will consider skin health in terms of functional capacity, psychological well-being, and social inclusion. Conditions such as alopecia, vitiligo, and severe acne—while not life-threatening—can lead to significant stigma, social withdrawal, and depression, particularly among adolescents and young adults.
The commission will also examine the intersection of skin health with environmental factors, including climate change, ultraviolet radiation exposure, and occupational hazards. Rising global temperatures are altering the geographic distribution of vector-borne skin diseases like leishmaniasis, while increased UV exposure contributes to growing rates of skin cancer in populations with historically low risk. In urban settings, air pollution and industrial chemicals are linked to rising rates of contact dermatitis and inflammatory skin conditions, particularly among workers in manufacturing, agriculture, and cleaning industries.
To inform its work, the commission will commission systematic reviews of existing literature, analyze data from the Global Burden of Disease Study, and conduct consultations with frontline health workers in underserved communities. It will also evaluate innovative delivery models, such as teledermatology programs in rural Australia and mobile skin clinics in parts of Brazil and India, to assess their scalability and cost-effectiveness.
Why Skin Health Has Been Overlooked in Global Health
Despite its high prevalence, skin disease has historically received limited attention in global health financing and policy agendas. A 2022 analysis published in The Lancet Global Health found that skin conditions accounted for approximately 1.79% of global disability-adjusted life years (DALYs), yet received less than 0.1% of development assistance for health between 2000 and 2019. Experts attribute this disparity to several factors: the perception that skin conditions are “not serious enough” to warrant priority funding, the lack of visible mortality associated with many dermatological disorders, and the fragmentation of dermatological care across specialties.
Unlike infectious diseases such as HIV or malaria, which have clear biomarkers and mortality endpoints, many skin conditions are chronic and episodic, making their impact harder to quantify in traditional health metrics. Dermatology is often viewed as a cosmetic or luxury specialty in low-resource settings, despite the fact that untreated skin infections can lead to sepsis, permanent disability, or social exclusion. The commission aims to challenge these misconceptions by presenting skin health not as a niche concern but as a determinant of overall well-being and economic participation.
Next Steps and Expected Timeline
The Lancet Commission on Global Skin Health is expected to convene its first meeting in mid-2024, with a final report scheduled for publication in 2026. The commission will operate under the editorial oversight of The Lancet, which will provide secretariat support and facilitate peer review of its findings. Upon release, the report will be accompanied by a series of policy briefs tailored for ministries of health, international donors, and civil society organizations.
ILDS has stated that it will use the commission’s outputs to advocate for the inclusion of skin health indicators in WHO’s Universal Health Coverage (UHC) monitoring framework and to support the development of national skin health strategies in member countries. The organization also plans to launch a global skin health workforce initiative aimed at training 50,000 community health workers in basic dermatological care by 2030.
For updates on the commission’s progress, readers can follow announcements from The Lancet’s official website and the International League of Dermatological Societies. Both organizations regularly publish newsletters, policy updates, and event calendars related to global dermatology initiatives.
As global health continues to evolve beyond infectious disease control toward a more holistic understanding of well-being, the Lancet commission on skin health represents a timely effort to ensure that the body’s largest organ is no longer overlooked in the pursuit of health for all.
We invite readers to share their perspectives on this development in the comments below and to share this article with colleagues and networks interested in global health equity.